(Circulation. 1995;92:2929-2934.)
© 1995 American Heart Association, Inc.
Articles |
From the Departments of Medicine (A.J.M., W.Z.), Community and Preventive Medicine (A.J.M., J.L.R.), and Biostatistics (W.J.H.), University of Rochester (NY) School of Medicine and Dentistry; Heiden Department of Cardiology, Bikur Cholim Hospital, Jerusalem, Israel (J.B.); Istituto di Clinica Medica Generale e Terapia Medica, University of Milan, Italy (E.H.L.); Section of Cardiology, Department of Internal Medicine, University of Pavia and Policlinico San Matteo IRCCS, Pavia, Italy (P.J.S.); Department of Pediatric Cardiology, Baylor College of Medicine, Houston, Tex (J.A.T.); Cardiology Division, Eccles Program in Human Molecular Biology and Medicine, Department of Human Genetics, and Howard Hughes Medical Institute of the University of Utah Health Sciences Center (M.T.K.), Salt Lake City; Departments of Medicine (G.M.V., K.W.T.) and Internal Medicine (G.M.V.), University of Utah School of Medicine, Salt Lake City; Arrhythmia Center, Sinai Hospital, Detroit, Mich (M.H.L.); and Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, Tex (J.W.M.).
Correspondence to Arthur J. Moss, MD, Heart Research Follow-up Program, Box 653, University of Rochester Medical Center, Rochester, NY 14642. E-mail heartajm@heart.heart.rochester.edu.
| Abstract |
|---|
|
|
|---|
Methods and Results Five quantitative ECG repolarization parameters, ie, four Bazett-corrected time intervals (QTonset-c, QTpeak-c, QTc, and Tduration-c, in milliseconds) and the absolute height of the T wave (Tamplitude, in millivolts), were measured in 153 members of six families with long QT syndrome linked to markers on chromosomes 3 (n=47), 7 (n=30), and 11 (n=76). Genotypic data were used to define each family member as being affected or unaffected with long QT syndrome. Affected members of all six families had longer QT intervals (QTonset-c, QTpeak-c, or QTc) than unaffected family members (P<.01). Each of the three long QT syndrome genotypes was associated with somewhat distinctive ECG repolarization features. Among affected individuals, the QTonset-c was unusually prolonged in those individuals with mutations involving the cardiac sodium channel gene SCN5A on chromosome 3 (lead II QTonset-c [mean±SD]: chromosome 3, 341±42 ms; chromosome 7, 290±56 ms; chromosome 11, 243±73 ms; P<.001); Tamplitude was generally quite small in the chromosome 7 genotype (lead II Tamplitude, mV: chromosome 3, 0.36±0.14; chromosome 7, 0.13±0.07; chromosome 11, 0.37±0.17; P<.001); and Tduration was particularly long in the chromosome 11 genotype (lead II Tduration-c: chromosome 3, 187±33 ms; chromosome 7, 191±51 ms; chromosome 11, 262±65 ms; P<.001). Similar ECG findings were observed in leads aVF and V5. A considerable variability exists in the quantitative repolarization parameters associated with each genotype, with overlap in the T-wave patterns among the three genotypes.
Conclusions Three separate genetic loci for the long QT syndrome including mutations in two cardiac ionic channel genes were associated with different phenotypic T-wave patterns on the ECG. This study provides insight into the influence of genetic factors on ECG manifestations of ventricular repolarization.
Key Words: electrocardiography genetics intervals arrhythmia
| Introduction |
|---|
|
|
|---|
Several quantitatively abnormal ECG characteristics have been described in patients with long QT syndrome.10 Among individuals with long QT syndrome and QTc prolongation, the morphology of the T wave is frequently unusual, with a spectrum of configurations.11 In two recent studies, the clinical significance of notched or biphasic T waves was reported in patients with long QT syndrome.12 13
In reviewing the ECGs from members of families with long QT syndrome having three different genotypes,3 7 we noted similar morphological repolarization patterns among patients with the same gene linkage and dissimilar repolarization patterns in patients with long QT with linkage to different gene loci. The purpose of this study is to investigate the ECG T-wave patterns (phenotypes) in patients with the long QT syndrome from families showing linkage to three different gene loci.
| Methods |
|---|
|
|
|---|
ECG Variables
The first 12-lead ECG obtained on each patient
was
analyzed in terms of specific time intervals and signal
amplitudes, with particular attention to the quantitative
characteristics of ventricular repolarization. T-Wave
alternans was not present on any of the baseline ECGs.
Ventricular ectopic beats were rare, and sinus beats
following the pause after an ectopic premature beat were not selected
for analysis. When marked sinus arrhythmia was
present and the recorded lead was long enough to identify this
rhythm, the next complex after the shortest RR interval was selected
for analysis, as recommended by Martin et al.14 In
each subject, measurements describing cycle length, QRS duration, and
T-wave morphology were made on one representative
complex in leads II, aVF, and V5. The RR (ms) interval
duration was measured in the cycle preceding the analyzed
repolarization pattern. T-Wave patterns were evaluated using five
quantitative parameters, with correction (c) for heart rate
using the Bazett formula15 for rate-dependent
parameters (parameterc=measured
parameter/s
). We report the
Bazett-corrected parameters in the same units as the
original parameter, as recently recommended by Molnar et
al.16 The five parameters were as follows: (1)
QTonset-c (ms), the time interval from the Q wave to
the point at which the T wave departs from the flat portion of the ST
segment; (2) QTpeak-c (ms), the time interval from the
Q wave to the positive or negative peak of the T wave; (3)
QTc (ms), the time interval from the Q wave to the end of
the T wave, defined as the point of its merger with the isoelectric
line. When a discrete U wave interrupted the T wave before the latter
returned to the baseline, the end of the T wave was defined as the
nadir of the curve between the T and U waves. (4)
Tduration-c (ms), the overall duration of the T
wave from the T wave onset to the end of the T wave; and (5)
Tamplitude (mV), the absolute amplitude of the T wave from
the extrapolated PR segmentbaseline to the T-wave peak. In this
study population, low-amplitude notches on the downslope of the T
wave13 were observed in 17% of the affected and 5% of
the unaffected family members; discrete U waves were observed in 21%
of the affected and 53% of the unaffected family members. Time and
amplitude measurements of T-wave notches and QT-U intervals were not
used in the evaluation of T-wave patterns in the current
analyses.
Statistical Analysis
Two separate families were associated
with linkage to long QT
syndrome markers on each of three chromosomes. The affected and
unaffected members of each family for each chromosome were identified,
with the result that there were 12 subgroups. For continuous
variables, a Student's t test was used to evaluate
differences in a given parameter between two subgroups, and
a one-way ANOVA test was performed to evaluate differences among
multiple subgroups.17 For dichotomous variables,
2 tests were performed to detect differences in
the distribution of the variable among two or more subgroups.
For each of the five repolarization parameters, ANOVA was performed to evaluate family differences and differences between affected and unaffected members from families linked to markers on each chromosome. The parameter Tamplitude was analyzed in logarithmic units due to skewness and increasing variability with increasing mean values; reported probability values for Tamplitude were derived from such analyses. Pairs of subgroups were compared by use of pooled t tests. Because parameters sometimes differed between the two families associated with a single chromosome, data were never pooled across such families; instead, means from two families were averaged and the standard errors then determined (the square root of the sum of squared standard errors, using pooled standard deviations). Such averages were then compared by use of Student's t tests or F tests. To assess differences in the repolarization parameters between two families, analyses were performed with stratification by affected/unaffected status.
Eight family members were taking ß-adrenergic blockers when the ECG was recorded. Exclusion of these eight individuals had a negligible effect on the findings. The reported findings are for the entire study population inclusive of these eight individuals.16
| Results |
|---|
|
|
|---|
2 analysis (P>.10). At the
time of the analyzed ECG, therapy with ß-adrenergic
blocking agents was relatively infrequent in both unaffected (1.3%)
and affected (9.2%) family members. No family member had undergone
left cervicothoracic sympathetic ganglionectomy before the baseline ECG
recording.
|
|
|
Repolarization Characteristics
Quantitative ECG
repolarization parameters in
unaffected and affected members of families with long QT syndrome
linked to markers on chromosomes 3, 7, and 11 are presented in
Tables 1
, 2
, and 3
, respectively.
The ECG data in these tables are for
lead II; similar findings were obtained when using quantitative
parameters from leads aVF and V5.
In the two families
showing linkage to markers on chromosome 3 (Table 1
), all
affected individuals had identical mutations in the cardiac
sodium channel gene SCN5A.8 On average, those
affected with this sodium channel gene abnormality had significantly
prolonged repolarization parameters
(QTonset-c, QTpeak-c, and
QTc) compared with unaffected members of the same family
(P<.001; Table 1
). T-wave duration and amplitude
were
similar in unaffected and affected members in each of the two families.
RR interval was longer in affected than in unaffected members of both
families (P<.05). The two families had similar
repolarization characteristics except that Tduration-c
was longer in family 1 than in family 2 (P<.01).
Long QT
syndrome in two families was linked to markers on chromosome 7
(Table 2
). On average, the affected members of both of these
families
had significantly prolonged QTc intervals
(P<.01) and reduced T-wave amplitudes (P=.02)
compared with unaffected members. Repolarization characteristics of the
two families were similar.
In two other families, long QT syndrome was
linked to markers on
chromosome 11 (Table 3
). When compared with unaffected members
of the
same family, affected family members had significantly prolonged
repolarization parameters
(QTonset-c, QTpeak-c, and
QTc; P<.01), a trend toward a prolonged
Tduration-c (P<.01 in one of the two
families), and similar T-wave amplitudes. Repolarization
characteristics of the two families were similar except that
Tduration-c was longer in family 5 than in family 6
(P<.01).
Comparison of Repolarization Characteristics in the Three
Genotypes
Comparisons by chromosome of the five repolarization
parameters in ECG leads II, aVF, and V5 among
affected individuals are presented in Table 4
. The T-wave
parameters were
significantly different among the three genotypes in each of
the three leads with the single exception of
Tduration-c in lead aVF. Each of the three long QT
syndrome genotypes had distinctive repolarization patterns. The
QT parameters (QTonset-c,
QTpeak-c, and QTc) were most
prolonged among affected members with the chromosome 3
genotype. Tamplitude was smallest in the chromosome
7 genotype, and Tduration-c was longest in the
chromosome 11 genotype.
|
Repolarization parameters among the unaffected
members of
the six families also differed to some degree (Tables 1 through
3![]()
![]()
). We
therefore examined the differences in mean values for repolarization
parameters between affected and unaffected family members,
taking the average of the two families associated with each chromosome
(Table 5
). Affected individuals carrying the abnormal
gene on chromosome 3 had especially prolonged QT intervals, with T
waves of normal duration and amplitude. Affected individuals carrying
the abnormal gene on chromosome 7 had moderately prolonged QT intervals
and low T-wave amplitude. Affected patients carrying the abnormal gene
on chromosome 11 had moderately prolonged QT intervals and prolonged
T-wave duration.
|
Examples of ECGs that reflect the distinguishing
repolarization
characteristics described in Tables 1 through
5![]()
![]()
![]()
![]()
for affected family
members carrying abnormal genes for long QT syndrome on chromosome 3,
7, and 11 are presented in the Figure
. It should
be emphasized that within a specific genotype, variability
exists in the ECG repolarization pattern among affected family members,
and there is overlap in the T-wave morphology between affected and
unaffected individuals from a given family. Also, overlap exists in
T-wave patterns between affected individuals with different
genotypes, especially those from families in whom the syndrome
is linked to chromosomes 7 and 11. The ECG repolarization pattern was
most distinctive in affected individuals with SCN5A
mutations on chromosome 3 (the Figure
).
|
| Discussion |
|---|
|
|
|---|
Patients with mutations in the SCN5A sodium channel gene on chromosome 38 have a distinctive, late-appearing T wave that is clearly different from the low-amplitude, moderately delayed T wave observed in affected patients who are carriers of the abnormal gene on chromosome 7. Both of these repolarization patterns are different from the broad-based, prolonged T-wave pattern found in patients who are carriers of the abnormal gene on chromosome 11.
Several ionic currents are operative during ventricular repolarization, and considerable attention has been focused in the past on possible alterations in the delayed rectifier potassium current and the calcium current to explain the electrophysiological phenomena responsible for QT prolongation.18 Recent discoveries by Wang et al8 and Curran et al9 support the hypothesis that at least two forms of long QT syndrome result from mutations in cardiac ion channel genes that are involved in the structure and function of sodium and potassium channels.
Wang et al8 have pointed out that a mutation in the
SCN5A gene on chromosome 3 causes deletions in the critical
amino acid sequences in the sodium channel region responsible for fast
sodium inactivation.19 Subtle abnormalities of sodium
channel function, eg, delayed inactivation or altered voltage
dependence of channel inactivation, could delay repolarization and lead
to the QT prolongation observed in patients with this SCN5A
mutation (the Figure
).
The mean values for the quantitative repolarization
parameters in affected individuals of a given
genotype are quite different from the mean values of unaffected
family members (Tables 1 through
3![]()
![]()
) and from the mean values of
affected individuals with different genotypes (Table 4
). It is
quite obvious from Tables 1 through
5![]()
![]()
![]()
![]()
that considerable variability
exists in the quantitative repolarization parameters within
families, between families, and among the three genotypes for
both affected and unaffected individuals. This quantitative variability
reflects the spectrum of observed repolarization patterns and the
overlap that exists in the ECG phenotypes among the three
different genotypes with long QT syndrome. This variability and
overlap are not unexpected; the expression of mutated genes is
influenced not only by the genetic milieu20 but also by
age, sex, heart rate, and various acquired factors. Vincent et
al21 previously showed a substantial overlap in the
QTc interval among carriers and noncarriers of the abnormal
gene on chromosome 11 for long QT syndrome, a finding
consistent with variable penetrance. Among the acquired
factors, ß-adrenergic blocker therapy has been reported to modify
the notched T-wave pattern in some patients with long QT
syndrome.12 ß-Blocker therapy was infrequently used in
the affected individuals at the time of the baseline ECG in the
present study, and exclusion of these individuals had only a
negligible influence on the observed repolarization patterns. Thus,
there is no evidence that ß-blockers had a meaningful effect on
the T-wave patterns in this population.
The present study highlights the relation between genotype and ECG phenotype in the hereditary long QT syndrome. Because multiple genetic and acquired factors can influence ventricular repolarization, it is unlikely that the morphological pattern of the T wave can be used to accurately identify the genotype in patients with suspected long QT syndrome. Rather, this study provides new insight into the genetic determinants of ventricular repolarization as manifested by various phenotypic T-wave patterns on the ECG in three different long QT syndrome genotypes. A larger number of families and affected members with the long QT syndrome is needed to evaluate the clinical implications of the different genotypes and the associated ECG phenotypes regarding the occurrence of arrhythmic cardiac events such as syncope, aborted cardiac arrest, and sudden cardiac death.
| Acknowledgments |
|---|
Received May 11, 1995; revision received July 12, 1995; accepted August 3, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. Goldenberg and A. J. Moss Long QT syndrome. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2291 - 2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Roden Long-QT Syndrome N. Engl. J. Med., January 10, 2008; 358(2): 169 - 176. [Full Text] [PDF] |
||||
![]() |
V. L. Vetter Clues or Miscues?: How to Make the Right Interpretation and Correctly Diagnose Long-QT Syndrome Circulation, May 22, 2007; 115(20): 2595 - 2598. [Full Text] [PDF] |
||||
![]() |
H. L. Tan, A. Bardai, W. Shimizu, A. J. Moss, E. Schulze-Bahr, T. Noda, and A. A. M. Wilde Genotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome: Possible Therapy Implications Circulation, November 14, 2006; 114(20): 2096 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Heradien, A. Goosen, L. Crotti, G. Durrheim, V. Corfield, P. A. Brink, and P. J. Schwartz Does Pregnancy Increase Cardiac Risk for LQT1 Patients With the KCNQ1-A341V Mutation? J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1410 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Locati QT Interval Duration Remains a Major Risk Factor in Long QT Syndrome Patients J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1053 - 1055. [Full Text] [PDF] |
||||
![]() |
S. A. Strickberger, D. W. Benson, I. Biaggioni, D. J. Callans, M. I. Cohen, K. A. Ellenbogen, A. E. Epstein, P. Friedman, J. Goldberger, P. A. Heidenreich, et al. AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society J. Am. Coll. Cardiol., January 17, 2006; 47(2): 473 - 484. [Full Text] [PDF] |
||||
![]() |
S. A. Strickberger, D. W. Benson, I. Biaggioni, D. J. Callans, M. I. Cohen, K. A. Ellenbogen, A. E. Epstein, P. Friedman, J. Goldberger, P. A. Heidenreich, et al. AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: In Collaboration With the Heart Rhythm Society: Endorsed by the American Autonomic Society Circulation, January 17, 2006; 113(2): 316 - 327. [Full Text] [PDF] |
||||
![]() |
G. Berecki, J. G. Zegers, Z. A. Bhuiyan, A. O. Verkerk, R. Wilders, and A. C. G. van Ginneken Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique J. Physiol., January 15, 2006; 570(2): 237 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Napolitano, S. G. Priori, P. J. Schwartz, R. Bloise, E. Ronchetti, J. Nastoli, G. Bottelli, M. Cerrone, and S. Leonardi Genetic Testing in the Long QT Syndrome: Development and Validation of an Efficient Approach to Genotyping in Clinical Practice JAMA, December 21, 2005; 294(23): 2975 - 2980. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Brink, L. Crotti, V. Corfield, A. Goosen, G. Durrheim, P. Hedley, M. Heradien, G. Geldenhuys, E. Vanoli, S. Bacchini, et al. Phenotypic Variability and Unusual Clinical Severity of Congenital Long-QT Syndrome in a Founder Population Circulation, October 25, 2005; 112(17): 2602 - 2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shimizu The long QT syndrome: Therapeutic implications of a genetic diagnosis Cardiovasc Res, August 15, 2005; 67(3): 347 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Moss and P. J. Schwartz 25th Anniversary of the International Long-QT Syndrome Registry: An Ongoing Quest to Uncover the Secrets of Long-QT Syndrome Circulation, March 8, 2005; 111(9): 1199 - 1201. [Full Text] [PDF] |
||||
![]() |
W. Zareba, A. J. Moss, E. H. Locati, M. H. Lehmann, D. R. Peterson, W. J. Hall, P. J. Schwartz, G. M. Vincent, S. G. Priori, J. Benhorin, et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype J. Am. Coll. Cardiol., July 2, 2003; 42(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Veldkamp, R. Wilders, A. Baartscheer, J. G. Zegers, C. R. Bezzina, and A. A.M. Wilde Contribution of Sodium Channel Mutations to Bradycardia and Sinus Node Dysfunction in LQT3 Families Circ. Res., May 16, 2003; 92(9): 976 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, P. J. Schwartz, C. Napolitano, R. Bloise, E. Ronchetti, M. Grillo, A. Vicentini, C. Spazzolini, J. Nastoli, G. Bottelli, et al. Risk Stratification in the Long-QT Syndrome N. Engl. J. Med., May 8, 2003; 348(19): 1866 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Moss Long QT Syndrome JAMA, April 23, 2003; 289(16): 2041 - 2044. [Full Text] [PDF] |
||||
![]() |
S. M. Al-Khatib, N. M. A. LaPointe, J. M. Kramer, and R. M. Califf What Clinicians Should Know About the QT Interval JAMA, April 23, 2003; 289(16): 2120 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fabritz, P. Kirchhof, M. R Franz, D. Nuyens, T. Rossenbacker, A. Ottenhof, W. Haverkamp, G. Breithardt, E. Carmeliet, and P. Carmeliet Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in {Delta}KPQ SCN5A (long QT3) mice Cardiovasc Res, March 15, 2003; 57(4): 1085 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takenaka, T. Ai, W. Shimizu, A. Kobori, T. Ninomiya, H. Otani, T. Kubota, H. Takaki, S. Kamakura, and M. Horie Exercise Stress Test Amplifies Genotype-Phenotype Correlation in the LQT1 and LQT2 Forms of the Long-QT Syndrome Circulation, February 18, 2003; 107(6): 838 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
I M Van Langen, E Birnie, M Alders, R J Jongbloed, H Le Marec, and A A M Wilde The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome J. Med. Genet., February 1, 2003; 40(2): 141 - 145. [Full Text] [PDF] |
||||
![]() |
X. H.T. Wehrens, M. A. Vos, P. A. Doevendans, and H. J.J. Wellens Novel Insights in the Congenital Long QT Syndrome Ann Intern Med, December 17, 2002; 137(12): 981 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rosen The Electrocardiogram 100 Years Later: Electrical Insights Into Molecular Messages Circulation, October 22, 2002; 106(17): 2173 - 2179. [Full Text] [PDF] |
||||
![]() |
M. R. Rosen Blunderbuss to Mickey Mouse: The Evolution of Antiarrhythmic Targets Circulation, September 3, 2002; 106(10): 1180 - 1182. [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Sympathetic modulation of the long QT syndrome Eur. Heart J., August 2, 2002; 23(16): 1246 - 1252. [PDF] |
||||
![]() |
T. Noda, H. Takaki, T. Kurita, K. Suyama, N. Nagaya, A. Taguchi, N. Aihara, S. Kamakura, K. Sunagawa, K. Nakamura, et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome Eur. Heart J., June 2, 2002; 23(12): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gima and Y. Rudy Ionic Current Basis of Electrocardiographic Waveforms: A Model Study Circ. Res., May 3, 2002; 90(8): 889 - 896. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wedekind, J. P.P. Smits, E. Schulze-Bahr, R. Arnold, M. W. Veldkamp, T. Bajanowski, M. Borggrefe, B. Brinkmann, I. Warnecke, H. Funke, et al. De Novo Mutation in the SCN5A Gene Associated With Early Onset of Sudden Infant Death Circulation, September 4, 2001; 104(10): 1158 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F Gilmour Jr. Life out of balance: The sympathetic nervous system and cardiac arrhythmias Cardiovasc Res, September 1, 2001; 51(4): 625 - 626. [Full Text] [PDF] |
||||
![]() |
A. A.M. Wilde and D. Escande LQT genotype-phenotype relationships: patients and patches Cardiovasc Res, September 1, 2001; 51(4): 627 - 629. [Full Text] [PDF] |